Back to User profile » Ms Dilraba Elihamu

Paper published by Ms Dilraba Elihamu:


Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer

Aimaiti X, Wang Y, Ismtula D, Li Y, Ma H, Wang J, Elihamu D, Guo C

Breast Cancer: Targets and Therapy 2025, 17:755-779

Published Date: 29 August 2025